Gene · 2271
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Research progress of nanocarriers for gene therapy targeting abnormal glucose and lipid metabolism in tumors. | Drug Deliv | 2021 | 34730054 | PubTator, text mining | PubMed |
| Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair. | Nat Commun | 2021 | 34728620 | PubTator, text mining | PubMed |
| The existence of a nonclassical TCA cycle in the nucleus that wires the metabolic-epigenetic circuitry. | Signal Transduct Target Ther | 2021 | 34728602 | PubTator, text mining | PubMed |
| Protein profile of fiber types in human skeletal muscle: a single-fiber proteomics study. | Skelet Muscle | 2021 | 34727990 | PubTator, text mining | PubMed |
| Roles of metal ions in the selective inhibition of oncogenic variants of isocitrate dehydrogenase 1. | Commun Biol | 2021 | 34725432 | PubTator, text mining | PubMed |
| Complete Response of Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC)-Associated Renal Cell Carcinoma to Pembrolizumab Immunotherapy: A Case Report. | Front Oncol | 2021 | 34722283 | PubTator, text mining | PubMed |
| Mitochondrial dysfunction, UPRmt signaling, and targeted therapy in metastasis tumor. | Cell Biosci | 2021 | 34717757 | PubTator, text mining | PubMed |
| A subpopulation of arenavirus nucleoprotein localizes to mitochondria. | Sci Rep | 2021 | 34702948 | PubTator, text mining | PubMed |
| Aberrant Metabolism as Inductor of Epigenetic Changes in Breast Cancer: Therapeutic Opportunities. | Front Oncol | 2021 | 34692471 | PubTator, text mining | PubMed |
| Manganese toxicity disrupts indole acetic acid homeostasis and suppresses the CO2 assimilation reaction in rice leaves. | Sci Rep | 2021 | 34686733 | PubTator, text mining | PubMed |
| Macrosphelide A Exhibits a Specific Anti-Cancer Effect by Simultaneously Inactivating ENO1, ALDOA, and FH. | Pharmaceuticals (Basel) | 2021 | 34681284 | PubTator, text mining | PubMed |
| The Morphological Spectrum of Papillary Renal Cell Carcinoma and Prevalence of Provisional/Emerging Renal Tumor Entities with Papillary Growth. | Biomedicines | 2021 | 34680535 | PubTator, text mining | PubMed |
| Bilateral Adrenal Hyperplasia: Pathogenesis and Treatment. | Biomedicines | 2021 | 34680514 | PubTator, text mining | PubMed |
| MicroRNAs and Metabolism: Revisiting the Warburg Effect with Emphasis on Epigenetic Background and Clinical Applications. | Biomolecules | 2021 | 34680164 | PubTator, text mining | PubMed |
| Multidetector CT Characteristics of Fumarate Hydratase-Deficient Renal Cell Carcinoma and Papillary Type II Renal Cell Carcinoma. | Korean J Radiol | 2021 | 34668351 | PubTator, text mining | PubMed |
| Mitochondrial genome and its regulator TFAM modulates head and neck tumourigenesis through intracellular metabolic reprogramming and activation of oncogenic effectors. | Cell Death Dis | 2021 | 34663785 | PubTator, text mining | PubMed |
| Structural Transformation and Creativity Induced by Biological Agents during Fermentation of Edible Nuts from Terminalia catappa. | Molecules | 2021 | 34641422 | PubTator, text mining | PubMed |
| Emerging Roles of Energy Metabolism in Ferroptosis Regulation of Tumor Cells. | Adv Sci (Weinh) | 2021 | 34632727 | PubTator, text mining | PubMed |
| Mechanisms Governing Metabolic Heterogeneity in Breast Cancer and Other Tumors. | Front Oncol | 2021 | 34631530 | PubTator, text mining | PubMed |
| An updated genome-scale metabolic network reconstruction of Pseudomonas aeruginosa PA14 to characterize mucin-driven shifts in bacterial metabolism. | NPJ Syst Biol Appl | 2021 | 34625561 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2271/papers?page=48